Sep 2026· Nature reviews. Drug discovery· 0 citations· 267 references
Medicine
TL;DR
The recent surge in clinical trials combining weight loss-inducing GLP1RA therapies with drugs that preserve muscle tissue suggests that treatments that promote both healthspan and lifespan, or 'healthy ageing', are on the horizon.
Key mechanistic evidence demonstrating how targeted GM interventions and structured exercise regimens may synergistically counteract muscle decline is explored, to support the development of innovative therapeutic approaches combining exercise and GM modulation to improve muscle health, functional independence, and hea...
Ana Sofia Merelim, Ângelo P. Santos, Rodrigo Zacca et al.· Sport Sciences for Health· 0 citations
Sarcopenia is a progressive skeletal muscle disorder characterised by reduced muscle strength, impaired muscle quantity or quality, and declining physical performance, with important consequences for falls, fractures, disability, and loss of independence. Whether sarcopenia prevalence itself is rising remains difficult...
F. Pan, F. Cicuttini· Baillière's Best Practice &...· 0 citations
Sarcopenia is a progressive skeletal muscle disorder in which clinically relevant muscle failure is expressed primarily as reduced muscle strength, with low muscle quantity or quality used to confirm the diagnosis and impaired physical performance indicating greater severity in the EWGSOP2 (European Working Group on Sa...
E. Główczewska-Siedlecka, M. Szafrańska, Agata Doligalska-Dolina et al.· Journal of Gerontology and G...· 0 citations
Skeletal muscle aging is a major cause of frailty, metabolic dysfunction, and loss of independence in later life, yet it cannot be explained by muscle mass loss alone. Recent single‐cell, multi‐omics, and translational studies show that aged muscle is shaped by coordinated changes in myofibers, stem and stromal cells,...
Sarcopenia is a major driver of disability, frailty, and loss of independence in ageing populations. Current consensus definitions have shifted from low muscle mass to low muscle strength and impaired physical performance as the defining clinical features. The underlying disease model, however, has remained predominant...
L. B. R. Orssatto, W. D. Arnold, L. Ferrucci et al.· The Lancet Healthy Longevity· 1 citation
Sarcopenia remains underdiagnosed and undertreated, partly because it continues to be mainly conceptualised as a disorder intrinsic to skeletal muscle. Although current definitions incorporate muscle strength and physical performance, they are not intended to explain the integrated physiological processes that underlie...
Luigi Ferrucci, S. Donegà, A. Picca et al.· The Lancet Healthy Longevity· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.